Concepedia

Ronan Chaligné

RC

11

Publications

662

Citations

11

H-Index

2007

Active since

Affiliations

Institut Gustave Roussy(Current)

Inserm

Université Paris-Saclay

Assistance Publique – Hôpitaux de Paris

Université Paris-Est Créteil

Ronan Chaligné is an author at Institut Gustave Roussy specializing in tumor biology, medicine, and peptide science.

ORCID

Top concepts

Publications per year

2007–2025

11

Publications

11

New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition

Ronan Chaligné, Carole Tonetti, Rodolphe Besancenot et al. · Leukemia · 2008 · 111 citations

, , +11

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Chloé James, Frédéric Mazurier, Sabrina Dupont et al. · Blood · 2008 · 103 citations · Full text

A Senescence-Like Cell-Cycle Arrest Occurs During Megakaryocytic Maturation: Implications for Physiological and Pathological Megakaryocytic Proliferation

Rodolphe Besancenot, Ronan Chaligné, Carole Tonetti et al. · PLoS Biology · 2010 · 102 citations · Full text

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Ronan Chaligné, Chloé James, Carole Tonetti et al. · Blood · 2007 · 97 citations · Full text

Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor

C. Pecquet, Judith Staerk, Ronan Chaligné et al. · Blood · 2009 · 73 citations

Rows per page

1–5 of 11